Company Overview - Sterling Infrastructure (STRL) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The company has shown significant price performance, with shares up 37.91% over the past quarter and 43.35% over the last year [7] Price Performance - STRL shares increased by 9.15% over the past week, outperforming the Zacks Engineering - R and D Services industry, which rose by 0.59% [6] - The monthly price change for STRL is 35.5%, compared to the industry's 4.78% performance [6] Trading Volume - The average 20-day trading volume for STRL is 1,059,492 shares, indicating a bullish sign for the stock [8] Earnings Outlook - Over the past two months, one earnings estimate for STRL has moved higher, while none have moved lower, increasing the consensus estimate from $8.21 to $8.45 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions [10]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: Comstock Resources (CRK) - Comstock Resources currently holds a Momentum Style Score of B, indicating potential for strong performance based on price changes and earnings estimate revisions [3][12]. - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4][12]. Performance Metrics - Over the past week, CRK shares have increased by 10.22%, significantly outperforming the Zacks Oil and Gas - Exploration and Production - United States industry, which rose by only 0.04% [6]. - In a longer timeframe, CRK's shares have risen by 25.04% over the past month, compared to the industry's 7.35% [6]. - Over the last quarter, CRK shares increased by 24.22%, and over the past year, they have gained 119.13%, while the S&P 500 has seen declines of -5.75% and gains of only 10.63% respectively [7]. Trading Volume - CRK's average 20-day trading volume is 2,086,099 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the last two months, 4 earnings estimates for CRK have been revised upwards, while only 2 have been revised downwards, leading to an increase in the consensus estimate from $0.59 to $0.73 [10]. - For the next fiscal year, 5 estimates have moved higher with no downward revisions, indicating a positive earnings outlook [10].

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

Group 1: BioCryst Pharmaceuticals, Inc. (BCRX) - BioCryst has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 285.7% over the last 60 days [1] - The company's shares gained 15% over the last three months, while the S&P 500 declined by 7.2% [1] - BioCryst possesses a Momentum Score of A [1] Group 2: WidePoint Corporation (WYY) - WidePoint has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 108.3% over the last 60 days [2] - The company's shares gained 35.7% over the last three months, compared to the S&P 500's decline of 7.2% [2] - WidePoint possesses a Momentum Score of B [2] Group 3: Rambus Inc. (RMBS) - Rambus has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 3.9% over the last 60 days [3] - The company's shares gained 11.6% over the past month, while the S&P 500 advanced by 6.9% [3] - Rambus possesses a Momentum Score of B [3]

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potential fails to justify their swelled-up valuation. In that phase ...

Core Viewpoint - Intesa Sanpaolo SpA (ISNPY) is identified as a strong momentum stock with a Zacks Rank of 1 (Strong Buy) and a Momentum Style Score of A, indicating potential for significant near-term gains [3][11]. Company Performance - ISNPY shares have increased by 1.34% over the past week, while the Zacks Banks - Foreign industry has risen by 2.06% during the same period [5]. - Over the last quarter, ISNPY shares have risen by 14.61%, and over the past year, they have increased by 37.26%. In comparison, the S&P 500 has moved -6.34% and 9.94% respectively [6]. - The average 20-day trading volume for ISNPY is 295,709 shares, which serves as a bullish indicator when combined with rising stock prices [7]. Earnings Outlook - In the past two months, one earnings estimate for ISNPY has been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $3.24 to $3.41 [9]. - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted in the same timeframe [9].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: Paymentus (PAY) - Paymentus currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating a favorable outlook for the stock [3][4]. - The stock has shown significant price performance, with a 10.13% increase over the past week and a 29.66% increase over the past month, outperforming the Zacks Financial Transaction Services industry, which saw a 0.24% and 2.18% increase respectively [6]. - Over the past quarter, shares of Paymentus have increased by 17.11%, and over the past year, they have gained 82.44%, while the S&P 500 has moved -6.34% and 9.94% respectively [7]. Trading Volume - The average 20-day trading volume for Paymentus is 428,243 shares, which serves as a baseline for price-to-volume analysis, indicating bullish or bearish trends [8]. Earnings Outlook - Recent earnings estimate revisions for Paymentus have been positive, with one estimate moving higher for the full year, increasing the consensus estimate from $0.57 to $0.59 over the past 60 days [10]. - For the next fiscal year, one estimate has also moved upwards, with no downward revisions noted [10]. Conclusion - Considering the positive momentum indicators and earnings outlook, Paymentus is positioned as a promising investment opportunity with a Momentum Score of B and a Zacks Rank of 2 (Buy) [12].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Summary: BioCryst Pharmaceuticals (BCRX) - BCRX currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] - Over the past week, BCRX shares increased by 6.44%, significantly outperforming the Zacks Medical - Drugs industry, which rose by 0.39% [5] - In a longer timeframe, BCRX's monthly price change is 48.89%, compared to the industry's 6.21% [5] - Over the last quarter, BCRX shares rose by 14.81%, and they have increased by 97.65% over the past year, while the S&P 500 saw movements of -6.34% and 9.94%, respectively [6] - The average 20-day trading volume for BCRX is 5,448,160 shares, indicating strong trading activity [7] Earnings Outlook - In the past two months, 6 earnings estimates for BCRX have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from -$0.07 to $0.13 [9] - For the next fiscal year, 6 estimates have also moved upwards without any downward revisions [9] Conclusion - Considering the strong momentum indicators and positive earnings outlook, BCRX is identified as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...

Group 1 - Zacks Premium offers tools for investors to enhance their stock market confidence and knowledge, including daily updates, research reports, and stock screens [1][2] - The Zacks Style Scores provide ratings based on value, growth, and momentum characteristics, helping investors identify stocks with high potential to outperform the market [2][3] Group 2 - The Value Score focuses on identifying undervalued stocks using financial ratios like P/E and Price/Sales [3] - The Growth Score emphasizes a company's financial health and future growth potential, analyzing projected and historical earnings [4] - The Momentum Score assists investors in capitalizing on price trends by evaluating recent price changes and earnings estimate shifts [5] Group 3 - The VGM Score combines all three Style Scores, offering a comprehensive assessment of stocks based on value, growth, and momentum [6] - The Zacks Rank, a proprietary stock-rating model, utilizes earnings estimate revisions to simplify portfolio building [7][8] Group 4 - Stocks with a Zacks Rank of 1 (Strong Buy) have historically produced an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] Group 5 - Palantir Technologies Inc. (PLTR) is currently rated 3 (Hold) with a VGM Score of B, indicating a moderate investment potential [12] - PLTR is projected to achieve year-over-year earnings growth of 36.6% for the current fiscal year, supported by upward revisions in earnings estimates [13]